Showing 4981-4990 of 23233 results for "".
Strategies for Communicating Bad News to Patients
https://reachmd.com/programs/clinicians-roundtable/strategies-for-communicating-bad-news-to-patients/4084/Breaking difficult news to patients is something that, as doctors, we have to do. Are there approaches that make it easier and clearer for the patient? In this segment, Dr. Alan Astrow, director of the division of hematology and medical oncology at Maimonides Cancer Center in New York City, joins hoExamining HIV "Elite Controller" Patients
https://reachmd.com/programs/clinicians-roundtable/examining-hiv-elite-controller-patients/3640/Chronic viral infections can manifest in two different ways: one group, such as Epstein-Barr virus, are immunologically contained after the acute infection. The other group, including HIV, lead to persistent viremia and progressive clinical disease. Are there patients who are able to escape the latPractice and Potential of Deep Brain Stimulation
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/practice-and-potential-of-deep-brain-stimulation/3384/Known as the ‘pacemaker for the brain,' deep brain stimulation has made noteworthy progress in treating Parkinson's disease. Dr. Gordon Baltuch, associate professor of neurosurgery and director of the Center for Functional and Restorative Neurosurgery at the University of Pennsylvania School of MediWhat Makes Women Tick? Could it Be Estrogen?
https://reachmd.com/programs/advances-in-womens-health/what-makes-women-tick-could-it-be-estrogen/3123/Dr. Oliver Schultheiss, chair of experimental psychology and neuroscience at Frederich-Alexander University in Erlangen, Germany, discusses his research into the effect of estrogen on the general temperament of women. Dr. Schultheiss tells host Dr. Lisa Mazzullo that estrogen levels may explain specTinnitus: A Disorder of the Ear or the Brain?
https://reachmd.com/programs/clinicians-roundtable/tinnitus-a-disorder-of-the-ear-or-the-brain/3088/We're learning more about tinnitus at a steady clip, as researchers use newer imaging modalities to help us understand the origin of the condition, and consider lifestyle and behavioral modifications that may limit its effects. Host Dr. Mark Nolan Hill explores the main causes of tinnitus with Dr. RUtilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
https://reachmd.com/programs/diabetes-discourse/utilizing-hybrid-closed-loop-technology-for-t1d-pediatric-patients/17885/Tune in to learn about a recent study on hybrid closed-loop technology in young children with type 1 diabetes.Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
https://reachmd.com/programs/project-oncology/treating-high-risk-biochemically-recurrent-prostate-cancer-an-update-from-asco-gu/17880/What are the outcomes of men with high-risk biochemically recurrent prostate cancer who suspended enzalutamide treatment? Tune in to find out.Dato-DXd’s Intracranial Efficacy in NSCLC: Insights from TROPION-Lung01
https://reachmd.com/programs/project-oncology/dato-dxd-intracranial-efficacy-nsclc/36609/A recent post-hoc analysis of the TROPION-Lung01 trial—which was presented at the 2025 World Conference on Lung Cancer—sheds light on the intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients with advanced non-small cell lung cancer (NSCLC) and baseline brain metastases. The findingATTR-CM Trials Revisited: A Broader View of Treatment Benefit
https://reachmd.com/programs/heart-matters/attr-cm-trials-treatment-benefit/49050/Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
https://reachmd.com/programs/living-rheum/delaying-rheumatoid-arthritis-with-abatacept-ariaa-trial-findings/32799/